Trends on clinical characteristics and medical service use of lung cancer in China 2005–14: a multicentre retrospective survey
Le Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Dai(Nanfang Hospital), Zhouguang Hui(Chinese Academy of Medical Sciences & Peking Union Medical College), Debin Wang(Anhui Medical University), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Yang(Guangxi Medical University), Huiyao Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaojing Xing(Liaoning Cancer Hospital & Institute), Shangmei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Junling Li(Tianjin Academy of Agricultural Sciences), Xianzhen Liao(Hunan Cancer Hospital), Jiansong Ren(Chinese Academy of Medical Sciences & Peking Union Medical College), Jufang Shi(Shanghai Jiao Tong University), Kai Zhang(China Pharmaceutical University), Yunchao Huang(North China University of Water Resources and Electric Power), Ning Wu(Regeneron (United States)), Boyan Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Yǒng-Zhèn Zhāng(Second Military Medical University), Juan Zhu(Guangdong Province Women and Children Hospital), Yuqin Liu(Qingdao University), Lingbin Du(Shandong University)
Cited by 1
Related Papers
Redefining the invertebrate RNA virosphere
|Nature|2016|1.8k
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
The evolutionary history of vertebrate RNA viruses
|Nature|2018|842